Is Minimal Residual Disease A Convincing Tool to Determine the Treatment Duration of Immune Checkpoint Inhibitors?
Author(s) -
Elie Rassy,
Tarek Assi,
Joseph Kattan
Publication year - 2016
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2016-0462
Subject(s) - medicine , limiting , oncology , cancer , immune checkpoint , immunotherapy , mechanical engineering , engineering
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom